4059711000001107: Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Nalidixic acid\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Nalidixic acid\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\UK product\Trade family\Uriben\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing nalidixic acid\Nalidixic acid\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing nalidixic acid\Nalidixic acid\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing nalidixic acid\Product containing nalidixic acid in oral dose form (medicinal product form)\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Medicinal product containing quinolone and acting as antibacterial agent (product)\Product containing nalidixic acid\Nalidixic acid\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Medicinal product containing quinolone and acting as antibacterial agent (product)\Product containing nalidixic acid\Nalidixic acid\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Medicinal product containing quinolone and acting as antibacterial agent (product)\Product containing nalidixic acid\Product containing nalidixic acid in oral dose form (medicinal product form)\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing quinolone and acting as antibacterial agent (product)\Product containing nalidixic acid\Nalidixic acid\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing quinolone and acting as antibacterial agent (product)\Product containing nalidixic acid\Nalidixic acid\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing quinolone and acting as antibacterial agent (product)\Product containing nalidixic acid\Product containing nalidixic acid in oral dose form (medicinal product form)\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing nalidixic acid in oral dose form (medicinal product form)\Product containing only nalidixic acid in oral dose form (medicinal product form)\Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension\Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17839901000001115 Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

17840001000001110 Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Is a	Product containing precisely nalidixic acid 60 milligram/1 milliliter conventional release oral suspension	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has excipient	Sorbic acid	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has active ingredient	Bactericide	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has active ingredient	Nalidixic acid	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has excipient	Paraben and/or paraben derivative	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has active ingredient	Substance with antibacterial mechanism of action	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral suspension	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Is a	Uriben	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has excipient	Hydroxybenzoates	false	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has specific active ingredient	Nalidixic acid	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release oral suspension	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml	Is pack of	False	Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml	Has AMP	True	Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17839901000001115	Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
17840001000001110	Uriben 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module